American Century Companies’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.03M | Sell |
149,259
-1,160
| -0.8% | -$8.95K | ﹤0.01% | 2317 |
|
|
2025
Q4 | $1.33M | Buy |
150,419
+4,155
| +3% | +$22.9K | ﹤0.01% | 2235 |
|
|
2025
Q3 | $730K | Buy |
146,264
+6,386
| +5% | +$29.6K | ﹤0.01% | 2405 |
|
|
2025
Q2 | $660K | Sell |
139,878
-138,913
| -50% | -$607K | ﹤0.01% | 2438 |
|
|
2025
Q1 | $1.28M | Sell |
278,791
-21,485
| -7% | -$100K | ﹤0.01% | 2166 |
|
|
2024
Q4 | $1.44M | Buy |
300,276
+6,079
| +2% | +$29.2K | ﹤0.01% | 2130 |
|
|
2024
Q3 | $1.38M | Buy |
294,197
+24,226
| +9% | +$130K | ﹤0.01% | 2122 |
|
|
2024
Q2 | $1.53M | Buy |
269,971
+18,733
| +7% | +$96.8K | ﹤0.01% | 2000 |
|
|
2024
Q1 | $1.03M | Buy |
251,238
+18,743
| +8% | +$75K | ﹤0.01% | 2137 |
|
|
2023
Q4 | $981K | Buy |
232,495
+15,549
| +7% | +$62.7K | ﹤0.01% | 2074 |
|
|
2023
Q3 | $937K | Buy |
216,946
+135,022
| +165% | +$750K | ﹤0.01% | 2014 |
|
|
2023
Q2 | $540K | Buy |
81,924
+62,458
| +321% | +$400K | ﹤0.01% | 2185 |
|
|
2023
Q1 | $131K | Sell |
19,466
-26,247
| -57% | -$185K | ﹤0.01% | 2502 |
|
|
2022
Q4 | $338K | Buy |
45,713
+7,000
| +18% | +$68.2K | ﹤0.01% | 2179 |
|
|
2022
Q3 | $382K | Buy |
+38,713
| New | +$409K | ﹤0.01% | 2050 |
|
|
2022
Q2 | – | Sell |
-55,245
| Closed | -$625K | – | 2388 |
|
|
2022
Q1 | $625K | Buy |
55,245
+141
| +0.3% | +$1.85K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $865K | Hold |
55,104
| – | – | ﹤0.01% | 1712 |
|
|
2021
Q3 | $944K | Buy |
55,104
+761
| +1% | +$13.3K | ﹤0.01% | 1619 |
|
|
2021
Q2 | $1.17M | Hold |
54,343
| – | – | ﹤0.01% | 1481 |
|
|
2021
Q1 | $816K | Buy |
54,343
+1,565
| +3% | +$25.3K | ﹤0.01% | 1527 |
|
|
2020
Q4 | $694K | Sell |
52,778
-30,474
| -37% | -$367K | ﹤0.01% | 1415 |
|
|
2020
Q3 | $804K | Buy |
83,252
+11,301
| +16% | +$121K | ﹤0.01% | 1178 |
|
|
2020
Q2 | $823K | Sell |
71,951
-26,311
| -27% | -$298K | ﹤0.01% | 1141 |
|
|
2020
Q1 | $1.02M | Buy |
98,262
+21,136
| +27% | +$262K | ﹤0.01% | 983 |
|
|
2019
Q4 | $1.27M | Sell |
77,126
-133,414
| -63% | -$2.02M | ﹤0.01% | 1056 |
|
|
2019
Q3 | $2.8M | Buy |
+210,540
| New | +$2.93M | ﹤0.01% | 917 |
|
|
2019
Q2 | – | Sell |
-113,208
| Closed | -$2.08M | – | 1351 |
|
|
2019
Q1 | $2.08M | Buy |
113,208
+1,103
| +1% | +$25.1K | ﹤0.01% | 985 |
|
|
2018
Q4 | $2.93M | Sell |
112,105
-43,326
| -28% | -$1.02M | ﹤0.01% | 909 |
|
|
2018
Q3 | $3.57M | Buy |
155,431
+95,325
| +159% | +$1.95M | ﹤0.01% | 923 |
|
|
2018
Q2 | $1.15M | Buy |
+60,106
| New | +$1.01M | ﹤0.01% | 1087 |
|
|
2016
Q4 | – | Sell |
-92,700
| Closed | -$1.54M | – | 1415 |
|
|
2016
Q3 | $1.54M | Buy |
+92,700
| New | +$1.25M | ﹤0.01% | 1099 |
|
Other funds holding VNDA
ACM
VCM
American Century Companies's VNDA Position: Q1 2026 in Review
American Century Companies reduced its Vanda Pharmaceuticals (VNDA) stake by 0.77% in Q1 2026, selling an estimated $8.95K and leaving 149,259 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2317.
American Century Companies first reported a position in VNDA in Q3 2016 and has held it in 31 quarters since. The position peaked at $3.57M in Q3 2018. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- American Century Companies held 149,259 shares of Vanda Pharmaceuticals worth $1.03M as of Q1 2026.
- American Century Companies sold 1,160 Vanda Pharmaceuticals shares in Q1 2026, an estimated $8.95K.
- Vanda Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2317 holding.
- American Century Companies first reported a position in Vanda Pharmaceuticals in Q3 2016 and has held it in 31 quarters since.
- American Century Companies's Vanda Pharmaceuticals position peaked at $3.57M in Q3 2018.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.